Metabolism of 36Cl-ornidazole after oral application to the male rat in relation to its antifertility activity.
1. The antimycotic ornidazole (a male antifertility agent in rats) was synthesized incorporating 36Cl in the chloropropyl sidechain and its metabolism was investigated in the male rat after oral ingestion. 2. Blood levels of radioactivity were low over the first 24 h and there was no tissue accumulation of radioactivity over 48 h. 3. Most of the excreted radioactivity (20% of the ingested dose) appeared in the urine within the first 24 h. 4. Three major compounds were detected in 0-24-h urine samples and were characterized as ornidazole (13% of total radioactivity), Cl- (22%) and 3-chlorolactate (30%), the oxidation product of 3-chlorolactaldehyde. 5. No polyuria or glucosuria was observed following the oral administration of ornidazole, suggesting that any (R)-3-chlorolactate produced was insufficient to affect renal metabolism. 6. Conversion of ornidazole initially to (R, S)-alpha-chlorohydrin or ultimately to the glycolytic inhibitor (S)-3-chlorolactaldehyde could explain its antifertility action in the male rat.
Jones
A R
AR
Department of Biochemistry, University of Sydney, NSW, Australia.
Cooper
T G
TG
D000284:Administration, Oral; D000818:Animals; D003272:Contraceptive Agents, Male / Q000378:metabolism*; D004231:Diuresis / Q000187:drug effects; D006029:Glycosuria / Q000139:chemically induced; D007668:Kidney / Q000378:metabolism*; D008297:Male; D009950:Ornidazole / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014018:Tissue Distribution
D003272:Contraceptive Agents, Male; D009950:Ornidazole